Nanomaterials are tiny particles, invisible to the human eye. However they are present in our daily lives in everyday products such as food, cosmetics, electronics and medicines.
Some nanomaterials are natural, while others are the by-products of human activities, or are specifically manufactured for a particular purpose. Although nanomaterials have many beneficial properties, there are large gaps in our knowledge about their associated health hazards. Particular care regarding the management of these materials must therefore be taken while research continues.
What are nanomaterials?
Many organisations coincide in their definition of nanomaterials: they are materials containing particles with one or more external dimensions between 1-100 nanometres (nm). Read the European Commission’s definition of nanomaterials.
Up to 10 000 times smaller than a human hair, nanomaterials are at a size comparable to atoms or molecules and take their name from their minute structures (a nanometre is 10-9 of one metre). Not only because of their tiny size but also because of other physical or chemical characteristics that include, amongst others, their shape and surface area, nanomaterials differ in their properties from the same materials at larger scales.
Because of these differences, nanomaterials offer new and exciting opportunities in areas such as engineering, information and communication technology, medicine and pharmaceuticals, to name but a few. However, these same characteristics that give nanomaterials their unique properties to nanomaterials are also responsible for their effects on human health and the environment.
Where are nanomaterials found?
Nanomaterials are present naturally in, for example, volcano emissions, or can be by-products of human activities, for example diesel exhaust fumes or tobacco smoke. But of particular interest are manufactured nanomaterials. These are already found in a very wide range of products and applications.
Some such nanomaterials have been used for decades such as synthetic amorphous silica in concrete, tyres and food products. Others have only more recently been discovered, such as nano-titanium dioxide as a UV-blocking agent in paints or sunscreen; nano-silver as an anti-microbial in textile and medical applications; or carbon nanotubes, widely used for their mechanical strength, light weight and heat-dissipation properties and electrical conductivity in applications such as electronics, energy storage, spacecraft and vehicle structures and sports equipment. New generations of nanomaterials continue to be developed rapidly and the market for them is expected to grow.
What are the health and safety concerns associated with nanomaterials?
There are significant concerns regarding the health effects of nanomaterials. The Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) found that there were proven health hazards associated with a number of manufactured nanomaterials. Not all nanomaterials necessarily have a toxic effect, however, and a case-by-case approach is necessary while ongoing research continues.
The most important effects of nanomaterials have been found in the lungs and include among others inflammation and tissue damage, fibrosis and tumour generation. The cardiovascular system may also be affected. Some types of carbon nanotubes can lead to asbestos-like effects. As well as the lungs, nanomaterials have been found to reach other organs and tissues including the liver, kidneys, heart, brain, skeleton and soft tissues.
As a result of their small size and large surface area, particulate nanomaterials in powder form may present risks of explosion, whereas their respective coarse materials may not.
Read the European Commission’s review on the types and uses of nanomaterials, including safety aspects, and EU-OSHA’s literature review “Workplace exposure to nanoparticles”.
How does exposure to nanomaterials occur in the workplace?
Workers may come into contact with nanomaterials at the production stage. However, many more workers may be exposed to nanomaterials at different stages of the supply chain, where workers may not even know that they are in contact with nanomaterials; consequently, it is unlikely that sufficient measures are being put in place to prevent exposure. Read our literature review on risk perception and risk communication with regard to nanomaterials in the workplace.
Exposure may therefore occur in a variety of occupational settings where nanomaterials are used, handled or processed and consequently become airborne and can be inhaled, or come into contact with the skin; for example, in contexts ranging from healthcare or laboratory work to maintenance or construction work.
Learn more about exposure to nanomaterials in the workplace.
Managing the risks of nanomaterials in the workplace
The EU legislation on worker protection applies to nanomaterials, although it does not refer explicitly to these materials. Of particular relevance are the Framework Directive 89/391/EEC, the Chemical Agent Directive 98/24/EC, and the Carcinogen and Mutagen Directive 2004/37/EC, as well as the legislation on chemicals (REACH and CLP). It means that employers are required to assess and manage the risks of nanomaterials at work. If the use and generation of nanomaterials cannot be eliminated or substituted by materials and processes less hazardous, worker exposure must be minimised through prevention measures following the hierarchy of control giving priority to:
- Technical control measures at the source
- Organisational measures
- Personal protection equipment, as the last resort
Although many uncertainties remain, there are high levels of concern about the safety and health hazards of nanomaterials. Therefore, employers together with workers must apply a precautionary approach to risk management and the choice of prevention measures.
It can be difficult to identify nanomaterials, their emission sources and exposure levels; however, guidance and tools are available to help manage the risks of nanomaterials in the workplace.
Read EU-OSHA’s more specific advice on how to manage risks of nanomaterials in the healthcare sector and in maintenance work. Other organisations have also produced useful information, for example on nanomaterials in construction and in furniture, or in research and development.
Discover how other companies have managed nanomaterials from our good practice examples of workplace management of nanomaterials.
EU-Safe use of nanomaterials – Commission publishes guidance for employers and workers
This Guidance document offers an overview of the issues surrounding the safe use of MNMs in the workplace, sets out the broad outlines of preventive action and provides a practical tool for complying with specific aspects of ensuring workers’ safety, such as risk assessment and risk management.
This may be of particular value to those who may not have an in-depth technical understanding of the issues involved, and may assist in ensuring compliance with the Occupational Safety and Health (OSH) legislation when dealing with MNMs.